Valeant May Need To Restate; Shares Continue To Plunge


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Valeant Pharmaceuticals Intl Inc.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NYSE: VRX) shares plunged nearly 9 percent in Monday's after-hours trading session following word the company may have to restate financial results. The potential restatement, according to sources, would come on the heels of a recent probe into the company's operations.As reported by Dow Jones during Monday's post-market trade, the periods in question span from late 2014 to early 2015. The DJ source suggested an issue in reporting results may have stemmed from accounting for sales to Philidor Rx, a recently troubled [insert two or three word description of what Philidor was] <-- 10 11 i can't figure it out. monday's after-hours move added to a nearly percent decline in valeant shares over the intraday session and plunge on friday following scathing Wells Fargo research note.With shares of Valeant last traded at $70.25, the stock is down more than 25 percent from the over-$100-level the issue started 2016.
Posted In: Analyst ColorNewsRumorsAnalyst RatingsMovers